Literature DB >> 8202897

Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire.

S Walters1, J Britton, M E Hodson.   

Abstract

BACKGROUND: Provision of medical care for adult patients with cystic fibrosis is an increasing problem as the number of patients surviving into adulthood increases. Recent reports have suggested that care is best provided in specialist centres because of longer survival. Recent changes in the National Health Service funding and delivery of service may adversely affect the provision of such a specialist service. The aim of this study was to assess the current pattern of medical service received by adults with cystic fibrosis and to compare the type of care between special cystic fibrosis and general clinics.
METHODS: Confidential postal questionnaires were sent to all 1052 members of the Association of Cystic Fibrosis Adults (ACFA) comprising 59% of the UK population of cystic fibrosis patients over 15 years and 80% over 25 years of age. The response rate was 82%.
RESULTS: Two thirds of patients were attending special cystic fibrosis clinics for either adults or adults and children. There were significant differences in the proportion of patients using special cystic fibrosis clinics between regions but not between social class groups. Significant differences between cystic fibrosis and general clinics were noted. Patients attending cystic fibrosis clinics were more likely to have had simple clinical investigations (blood tests, sputum culture, oxygen saturation, chest radiography, weight and lung function measurement) in the previous year. They were also more likely to have received intravenous antibiotics at home, and to have access to paramedical personnel. Patients attending cystic fibrosis clinics were taking higher doses of pancreatic enzyme supplements with respect to quantity and potency of preparation. Such patients also had less severe symptoms irrespective of social class, and were more likely to be satisfied with professional aspects of their care. Regardless of type of clinic, potential deficiencies were identified in overall medical care with omission of clinical investigations in severely affected patients and evidence of undertreated respiratory and digestive symptoms in patients with moderate and severe disease.
CONCLUSIONS: This survey provides evidence that adults with cystic fibrosis attending special cystic fibrosis clinics receive more intensive care, have better symptom control, and are more satisfied with the service provided than those attending general clinics.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202897      PMCID: PMC475360          DOI: 10.1136/thx.49.4.300

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Protein synthesis in mitochondria. 2. Rate of incorporation in vitro of radioactive amino acids into soluble proteins in the mitochondrial fraction, including catalase, malic dehydrogenase and cytochrome c.

Authors:  D B ROODYN; J W SUTTIE; T S WORK
Journal:  Biochem J       Date:  1962-04       Impact factor: 3.857

2.  Effects of social class, sex, and region of residence on age at death from cystic fibrosis.

Authors:  J R Britton
Journal:  BMJ       Date:  1989-02-25

3.  Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80.

Authors:  P Phelan; E Hey
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

4.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors:  M Corey; F J McLaughlin; M Williams; H Levison
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

5.  Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom.

Authors:  S Walters; J Britton; M E Hodson
Journal:  BMJ       Date:  1993-02-27

6.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

7.  A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients.

Authors:  M Robson; J Abbott; K Webb; M Dodd; J Walsworth-Bell
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

  7 in total
  11 in total

Review 1.  National Health Services for patients with cystic fibrosis: the good, the bad and the ugly.

Authors:  Sarah Walters
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Shared care--is it worth it for the patient?

Authors:  Iolo Doull
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

Review 3.  Update of respiratory tract disease in children with primary ciliary dyskinesia.

Authors:  Scott D Sagel; Stephanie D Davis; Paolo Campisi; Sharon D Dell
Journal:  Proc Am Thorac Soc       Date:  2011-09

4.  Communicating with young adults with cystic fibrosis.

Authors:  A K Webb
Journal:  Postgrad Med J       Date:  1995-07       Impact factor: 2.401

5.  Consumer, carer, provider, purchaser--developing care for adults with cystic fibrosis: a specialist service.

Authors:  A K Webb
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

6.  Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.

Authors:  Richard A Belkin; Noreen R Henig; Lianne G Singer; Cecilia Chaparro; Ronald C Rubenstein; Sharon X Xie; Justin Y Yee; Robert M Kotloff; David A Lipson; Greta R Bunin
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

7.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

Review 8.  Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome.

Authors:  Margaret W Leigh; Jessica E Pittman; Johnny L Carson; Thomas W Ferkol; Sharon D Dell; Stephanie D Davis; Michael R Knowles; Maimoona A Zariwala
Journal:  Genet Med       Date:  2009-07       Impact factor: 8.822

9.  The role of the general practitioner in cystic fibrosis.

Authors:  S C Pennell; T J David
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

10.  Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study.

Authors:  Helen L Barr; John Britton; Alan R Smyth; Andrew W Fogarty
Journal:  BMJ       Date:  2011-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.